Document is current
Any future updates will be listed below
-
Authors
Kaarijärvi, Roosa https://orcid.org/0000-0002-6857-3919
Kaljunen, Heidi https://orcid.org/0000-0002-5962-9503
Nappi, Lucia
Fazli, Ladan
Kung, Sonia H. Y. https://orcid.org/0000-0002-9230-8939
Hartikainen, Jaana M. https://orcid.org/0000-0001-8267-1905
Paakinaho, Ville https://orcid.org/0000-0003-4204-1436
Capra, Janne
Rilla, Kirsi https://orcid.org/0000-0002-7862-5727
Malinen, Marjo
Mäkinen, Petri I.
Ylä-Herttuala, Seppo https://orcid.org/0000-0001-7593-2708
Zoubeidi, Amina https://orcid.org/0000-0002-0498-142X
Wang, Yuzhuo https://orcid.org/0000-0002-9749-8591
Gleave, Martin E.
Hiltunen, Mikko
Ketola, Kirsi https://orcid.org/0000-0001-6484-9861
-
Funding
Funding for this research was provided by:
Academy of Finland, Sigrid Jusélius Foundation, Finnish Cultural Foundation, Finnish Cultural Foundation North Savo Regional Fund, the Cancer Foundation Finland.
- License Information
-
More Information
Article History
Received: 18 July 2023
Accepted: 22 December 2023
First Online: 18 January 2024
Competing interests
: The authors declare no competing interests.
: We obtained written informed consent from the patients and that the studies were conducted in accordance with recognized ethical guidelines UBC CREB number: H09-01628 and the amendment has been reviewed by the Chair of the University of British Columbia Clinical Research Ethics Board and the study protocol has been approved by the ethics committee on ethical grounds for research involving human subjects. All ethical regulations relevant to human research participants were followed.
